Breaking News Instant updates and real-time market news.

2021-01-27 05:21:58 MRLWF Marlowe $0.00 / + (+0.00%) 05:21 01/27/21 01/27 05:21 01/27/21 05:21	Marlowe initiated with a Buy at Peel Hunt Peel Hunt initiated coverage of Marlowe with a Buy rating and 753 GBp price target.

2021-01-27 05:21:58

MRLWF

Marlowe

$0.00 / + (+0.00%)

05:21

01/27/21

01/27

05:21

01/27/21

05:21

Marlowe initiated with a Buy at Peel Hunt

Peel Hunt initiated coverage of Marlowe with a Buy rating and 753 GBp price target.

TODAY'S FREE FLY STORIES

General news	FX Update: The dollar has traded firmer » 07:00 03/04/21 03/04 07:00 03/04/21 07:00 FX Update: The dollar has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Mallinckrodt announces publication of CONFIRM study results » 06:59 03/04/21 03/04 06:59 03/04/21 06:59 MNK Mallinckrodt $0.00 / + (+0.00%) Mallinckrodt announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Options MNK Mallinckrodt $0.00 / + (+0.00%) 02/26/21 Silence, Mallinckrodt initiate work on third target in collaboration 02/22/21 DBV Technologies appoints Michele Robertson as chief legal officer 02/12/21 Mallinckrodt announces FDA to defer action on StrataGraft BLA 11/16/20 Mallinckrodt announces findings from database review of HRS, AKI patients MNK Mallinckrodt $0.00 / + (+0.00%) 08/06/20 Citi Mallinckrodt price target lowered to $1 from $2 at Citi 08/05/20 BMO Capital Mallinckrodt price target lowered to $2 from $4 at BMO Capital 08/04/20 Piper Sandler Mallinckrodt downgraded to Underweight from Neutral at Piper Sandler 07/14/20 BMO Capital Briefing docs suggest AdComm 'challenges' for Mallinckrodt, says BMO Capital MNK Mallinckrodt $0.00 / + (+0.00%) 10/21/20 Purdue Pharma to plead guilty in $8B-plus deal, AP reports 09/25/20 Mallinckrodt nearing bankruptcy filing, negotiating with key creditors, WSJ says 09/25/20 Mallinckrodt nearing bankruptcy filing over opioid suits, WSJ says MNK Mallinckrodt $0.00 / + (+0.00%) 10/13/20 Three new option listings and three option delistings on October 13th 10/08/20 Largest borrow rate increases among liquid names
Upgrade	U.S. Xpress Enterprises upgraded to Buy from Neutral at BofA » 06:59 03/04/21 03/04 06:59 03/04/21 06:59 USX U.S. Xpress Enterprises / + BofA analyst Ken Hoexter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events USX U.S. Xpress Enterprises / + 01/22/21 U.S. Xpress Enterprises falls -13.8% 01/22/21 U.S. Xpress Enterprises falls -10.9% 01/22/21 U.S. Xpress Enterprises falls -11.1% 10/23/20 U.S. Xpress Enterprises falls -20.6% USX U.S. Xpress Enterprises / + 11/23/20 BofA BofA cuts three truckers to Neutral, double downgrades U.S. Xpress 11/23/20 BofA U.S. Xpress Enterprises downgraded to Underperform from Buy at BofA 10/15/20 Stifel U.S. Xpress Enterprises upgraded to Buy amid tight spot market at Stifel 10/15/20 Stifel U.S. Xpress Enterprises upgraded to Buy from Hold at Stifel USX U.S. Xpress Enterprises / + 01/28/21 U.S. Xpress Enterprises reports Q4 EPS 15c, consensus 18c 10/22/20 U.S. Xpress reports Q3 EPS 20c, consensus 21c USX U.S. Xpress Enterprises / + 01/28/21 Fly Intel: After-Hours Movers 10/22/20 Fly Intel: After-Hours Movers 03/15/21 2021 Industrials Virtual Conference
Recommendations	Wendy's should look outside organic growth plans, says Stifel » 06:59 03/04/21 03/04 06:59 03/04/21 06:59 WEN Wendy's / + Stifel analyst Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's / + 03/03/21 Wendy's CEO: Loyalty program driving frequency, should continue to pay dividends 03/03/21 Wendy's says Q1 sales 'off to a strong start' 03/03/21 Wendy's sees FY21 cash flows from operations: $310M-$330M 03/03/21 Wendy's reports Q4 global same-restaurant sales growth 4.7% WEN Wendy's / + 03/03/21 Wells Fargo Wells Fargo lowers Wendy's target to $22 as current performance misses mark 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank WEN Wendy's / + 03/03/21 Wendy's sees FY21 adjusted EPS 67c-69c, consensus 72c 03/03/21 Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's / + 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 03/16/21 Wendy's
Upgrade	Werner upgraded to Buy from Neutral at BofA » 06:59 03/04/21 03/04 06:59 03/04/21 06:59 WERN Werner / + BofA analyst Ken Hoexter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly WERN Werner / + 02/25/21 Werner increases quarterly cash dividend 11% to 10c per share 01/27/21 Werner announces sale of WGL unit to Scan Global Logistics Group 01/20/21 Werner announces equity investment in TuSimple 09/16/20 Werner, Platform Science announce technology partnership WERN Werner / + 01/26/21 Susquehanna Werner downgraded to Neutral from Positive at Susquehanna 01/26/21 Susquehanna Werner downgraded to Neutral from Positive at Susquehanna 01/19/21 Credit Suisse Werner upgraded to Neutral from Underperform at Credit Suisse 12/14/20 Wells Fargo Werner downgraded to Underweight from Equal Weight at Wells Fargo WERN Werner / + 02/04/21 Werner reports Q4 adjusted EPS 89c, consensus 78c 10/28/20 Werner reports Q3 EPS 69c, consensus 66c 04 Jun WERN Werner / + 10/28/20 Fly Intel: After-Hours Movers

Upgrade	Schneider National upgraded to Buy from Neutral at BofA » 06:58 03/04/21 03/04 06:58 03/04/21 06:58 SNDR Schneider National / + BofA analyst Ken Hoexter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SNDR Schneider National / + 01/20/21 Schneider National takes investment stake in TuSimple 12/16/20 Schneider National to increase driver pay in 2021 10/29/20 Schneider National declares special dividend of $2.00 per share SNDR Schneider National / + 02/01/21 KeyBanc Schneider National upgraded to Overweight from Sector Weight at KeyBanc 02/01/21 KeyBanc Schneider National upgraded to Overweight from Sector Weight at KeyBanc 01/26/21 Susquehanna Schneider National downgraded to Neutral from Positive at Susquehanna 01/26/21 Susquehanna Schneider National downgraded to Neutral from Positive at Susquehanna SNDR Schneider National / + 02/03/21 Schneider National sees FY21 adjusted EPS $1.45-$1.60, consensus $1.55 02/03/21 Schneider National reports Q4 adjusted EPS 44c, consensus 39c 10/29/20 Schneider National raises FY20 adj. EPS view to $1.18-$1.22 from $1.10-$1.25 10/29/20 Schneider National reports Q3 adj. EPS 31c, consensus 31c
Upgrade	Svenska Handelsbanken upgraded to Neutral from Sell at Citi » 06:58 03/04/21 03/04 06:58 03/04/21 06:58 SVNLY Svenska Handelsbanken $0.00 / + (+0.00%) Citi analyst Maria… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SVNLY Svenska Handelsbanken $0.00 / + (+0.00%) 02/05/21 Berenberg Svenska Handelsbanken price target raised to SEK 87 from SEK 83 at Berenberg 02/04/21 Deutsche Bank Svenska Handelsbanken price target raised to SEK 113 at Deutsche Bank 01/21/21 Barclays Svenska Handelsbanken price target raised to SEK 105 from SEK 102 at Barclays 01/14/21 SEB Equities Svenska Handelsbanken upgraded to Hold from Sell at SEB Equities
Upgrade	Knight-Swift upgraded to Buy from Neutral at BofA » 06:58 03/04/21 03/04 06:58 03/04/21 06:58 KNX Knight-Swift $45.27 / +0.76 (+1.71%) BofA analyst Ken Hoexter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options KNX Knight-Swift $45.27 / +0.76 (+1.71%) 02/01/21 Knight-Swift acquires majority stake in mobile driver workflow firm Eleos 09/29/20 Knight-Swift aims to reduce carbon emissions by 50% by 2035 KNX Knight-Swift $45.27 / +0.76 (+1.71%) 01/14/21 Citi Knight-Swift price target raised to $48 from $46 at Citi 01/07/21 Wolfe Research Knight-Swift downgraded to Peer Perform from Outperform at Wolfe Research 12/04/20 Evercore starts trucking coverage with preference for Old Dominion, Saia 12/04/20 Evercore ISI Knight-Swift initiated with an In Line at Evercore ISI KNX Knight-Swift $45.27 / +0.76 (+1.71%) 01/27/21 Knight-Swift reports Q4 adjusted EPS 94c, consensus 91c 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/21/20 Knight-Swift sees FY21 adj. EPS $3.20-$3.40, consensus $2.83 KNX Knight-Swift $45.27 / +0.76 (+1.71%) 10/05/20 Knight Transportation call buyer realizes 11% same-day gains
Hot Stocks	Eli Lilly announces results from SURPASS-2 clinical trial » 06:58 03/04/21 03/04 06:58 03/04/21 06:58 LLY Eli Lilly $201.93 / -2.24 (-1.10%) Tirzepatide led to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY Eli Lilly $201.93 / -2.24 (-1.10%) 03/03/21 Eli Lilly, Incyte announce BRAVE-AA2 study met primary endpoint 02/26/21 Eli Lilly awarded $210M Army contract for 100,000 doses of antibody therapeutic 02/26/21 Eli Lilly awarded $2.52B Army contract for LY-CoV555, LY-CoV016 02/26/21 Eli Lilly: Additional doses of neutralizing antibody therapy purchased by U.S. LLY Eli Lilly $201.93 / -2.24 (-1.10%) 03/02/21 JPMorgan Eli Lilly risk/reward favorable into Alzheimer's data, says JPMorgan 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 02/12/21 Cowen Eli Lilly price target raised to $235 from $195 at Cowen LLY Eli Lilly $201.93 / -2.24 (-1.10%) 01/29/21 Eli Lilly backs FY21 EPS view $7.75-$8.40, consensus $8.20 01/29/21 Eli Lilly reports Q4 EPS $2.75, consensus $2.35 01/28/21 Notable companies reporting before tomorrow's open 01/28/21 Notable companies reporting before tomorrow's open LLY Eli Lilly $201.93 / -2.24 (-1.10%) 02/10/21 Eli Lilly won't try to claw back past pay from former CFO Smiley, WSJ reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says LLY Eli Lilly $201.93 / -2.24 (-1.10%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 01/29/21 Fly Intel: Wall Street's top stories at midday 03/05/21 Healthcare 03/02/21 41st Annual Healthcare Virtual Conference 03/10/21 Global Healthcare Virtual Conference 2021 03/15/21 Eli Lilly - LLY 04/27/21 Eli Lilly - LLY LLY Eli Lilly $201.93 / -2.24 (-1.10%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th
Upgrade	J.B. Hunt upgraded to Buy from Neutral at BofA » 06:58 03/04/21 03/04 06:58 03/04/21 06:58 JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) BofA analyst Ken Hoexter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) 03/01/21 J.B. Hunt Chairman James Thompson sold over $750K in company shares 01/27/21 Navistar partners with General Motors, J.B. Hunt for hydrogen truck ecosystem 01/19/21 J.B. Hunt jumps 3% to $153.00 after Q4 earnings beat 01/19/21 J.B. Hunt says Q4 revenue growth driven by ICS and Truck segments JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) 01/26/21 Susquehanna J.B. Hunt downgraded to Neutral from Positive at Susquehanna 01/26/21 Susquehanna J.B. Hunt downgraded to Neutral from Positive at Susquehanna 01/21/21 Deutsche Bank J.B. Hunt price target raised to $146 from $139 at Deutsche Bank 01/20/21 JPMorgan J.B. Hunt shares will 'lag the group,' says JPMorgan JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) 01/19/21 J.B. Hunt reports Q4 EPS $1.44, consensus $1.30 01/19/21 Notable companies reporting after market close 10/16/20 J.B. Hunt reports Q3 EPS $1.18, consensus $1.27 10/15/20 Notable companies reporting before tomorrow's open JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) 01/30/21 Charged: Tesla reports first profit miss in over a year 01/19/21 Fly Intel: After-Hours Movers 10/16/20 Fly Intel: Pre-market Movers JBHT J.B. Hunt $152.57 / +1.7 (+1.13%) 01/19/21 J B Hunt Transport Services options imply 5.8% move in share price post-earnings 10/01/20 Early notable gainers among liquid option names on October 1st

Recommendations	Agco price target raised to $200 from $155 at BMO Capital » 06:57 03/04/21 03/04 06:57 03/04/21 06:57 AGCO Agco $126.04 / -3.1 (-2.40%) BMO Capital analyst Joel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AGCO Agco $126.04 / -3.1 (-2.40%) 03/03/21 AGCO announces farmer-first strategy 02/19/21 Agco says TAFE letter to board makes 'a number of misleading statements' 10/13/20 Agco chief communication officer Ulrich Stockheim to depart company AGCO Agco $126.04 / -3.1 (-2.40%) 06:52 Today Deutsche Bank Agco price target raised to $145 from $141 at Deutsche Bank 02/08/21 BMO Capital Agco price target raised to $155 from $130 at BMO Capital 01/20/21 Vertical Research Agco initiated with a Hold at Vertical Research 01/15/21 Jefferies Agco price target raised to $135 from $105 at Jefferies AGCO Agco $126.04 / -3.1 (-2.40%) 02/04/21 Agco sees FY21 EPS $7.00-$7.25, consensus $6.28 02/04/21 Agco reports Q4 EPS $1.54, consensus $1.11 11/03/20 Agco raises FY20 adj. EPS view to approximately $5.00 from $3.50-$3.75 11/03/20 Agco reports Q3 EPS $2.09, consensus 98c
Hot Stocks	Burlington Stores reports Q4 gross margin 42.5% vs. 42.1% last year » 06:55 03/04/21 03/04 06:55 03/04/21 06:55 BURL Burlington Stores $252.46 / -6.51 (-2.51%) Merchandise margins… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BURL Burlington Stores $252.46 / -6.51 (-2.51%) 06:47 Today Burlington Stores sees FY21 CapEx $470M 11/24/20 Burlington Stores lowers FY20 CapEx view to $245M from $400M BURL Burlington Stores $252.46 / -6.51 (-2.51%) 02/16/21 JPMorgan Burlington Stores price target raised to $259 from $254 at JPMorgan 01/27/21 Citi Burlington Stores downgraded to Neutral from Buy at Citi 01/22/21 Loop Capital Burlington Stores price target raised to $290 from $255 at Loop Capital 01/21/21 Deutsche Bank Burlington Stores price target raised to $279 from $246 at Deutsche Bank BURL Burlington Stores $252.46 / -6.51 (-2.51%) 06:46 Today Burlington Stores reports Q4 adjusted EPS $2.44, consensus $2.12 03/03/21 Notable companies reporting before tomorrow's open 03/03/21 Notable companies reporting before tomorrow's open 11/24/20 Burlington Stores reports Q3 non-GAAP EPS 29c, consensus 16c BURL Burlington Stores $252.46 / -6.51 (-2.51%) 11/24/20 Fly Intel: Pre-market Movers 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 10/28/20 AMD, Lululemon upgrades among today's top calls on Wall Street 10/27/20 Foot Locker, DocuSign initiations among today's top calls on Wall Street 08:30 Today Burlington Stores - BURL BURL Burlington Stores $252.46 / -6.51 (-2.51%) 10/09/20 Unusual call flow in option market yesterday 10/08/20 Call spread in Burlington Stores rolls two week 300% winner
Syndicate	TherapeuticsMD files $100M mixed securities shelf 06:55 03/04/21 03/04 06:55 03/04/21 06:55 TXMD TherapeuticsMD $1.46 / + (+0.00%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options TXMD TherapeuticsMD $1.46 / + (+0.00%) 11/09/20 TherapeuticsMD begins process to divest vitaCare Prescription Services 09/21/20 TherapeuticsMD, Knight announces Health Canada approval of BIJUVA 09/09/20 TherapeuticsMD announces patent updates for Annovera TXMD TherapeuticsMD $1.46 / + (+0.00%) 01/28/21 H.C. Wainwright TherapeuticsMD price target lowered to $4 from $5 at H.C. Wainwright 08/07/20 Jefferies Jefferies downgrades 'show-me story' TherapeuticsMD to Underperform 08/07/20 Jefferies TherapeuticsMD downgraded to Underperform from Hold at Jefferies 05/19/20 Fly Intel: Top five analyst downgrades TXMD TherapeuticsMD $1.46 / + (+0.00%) 03/02/21 TherapeuticsMD reports Q4 EPS (15c), consensus (10c) 11/09/20 TherapeuticsMD reports Q3 EPS (12c) with items, consensus (14c) 09/25/20 TherapeuticsMD says on track to meet or exceed Q3 revenue consensus of $15.1M 11 Feb 10 Nov TXMD TherapeuticsMD $1.46 / + (+0.00%) 02/10/21 Fly Intel: After-Hours Movers TXMD TherapeuticsMD $1.46 / + (+0.00%) 03/02/21 Unusually active option classes on open March 2nd 10/27/20 Largest borrow rate increases among liquid names 10/06/20 Largest borrow rate increases among liquid names 09/16/20 Largest borrow rate increases among liquid names
Recommendations	Dollar Tree price target lowered to $125 from $129 at RBC Capital » 06:55 03/04/21 03/04 06:55 03/04/21 06:55 DLTR Dollar Tree $101.79 / +2.75 (+2.78%) RBC Capital analyst Scot… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options DLTR Dollar Tree $101.79 / +2.75 (+2.78%) 03/03/21 Dollar Tree sees FY21 store openings of 600 02/16/21 SPAR Group appoints Mike Matacunas as president, CEO 02/04/21 Instacart announces new national delivery partnership with Family Dollar 12/07/20 Dollar Tree CEO sells 12.4K shares of common stock DLTR Dollar Tree $101.79 / +2.75 (+2.78%) 03/03/21 Wells Fargo Dollar Tree stage now set for share recovery, says Wells Fargo 02/25/21 Fly Intel: Pre-market Movers 02/25/21 BofA BofA double downgrades Dollar Tree to Underperform, sees multiple headwinds 02/25/21 BofA Dollar Tree downgraded to Underperform from Buy at BofA DLTR Dollar Tree $101.79 / +2.75 (+2.78%) 03/03/21 Dollar Tree reports Q4 EPS $2.13, consensus $2.11 11/24/20 Dollar Tree reports Q3 EPS $1.39, consensus $1.15 11/23/20 Notable companies reporting before tomorrow's open 11/23/20 Notable companies reporting before tomorrow's open DLTR Dollar Tree $101.79 / +2.75 (+2.78%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street DLTR Dollar Tree $101.79 / +2.75 (+2.78%) 12/16/20 Early notable gainers among liquid option names on December 16th 11/24/20 Early notable gainers among liquid option names on November 24th 10/23/20 Dollar Tree call volume above normal and directionally bullish
General news	European stock markets are broadly lower, » 06:55 03/04/21 03/04 06:55 03/04/21 06:55 European stock markets… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Recommendations	Okta price target lowered to $270 from $313 at Deutsche Bank » 06:53 03/04/21 03/04 06:53 03/04/21 06:53 OKTA Okta $242.42 / -16.595 (-6.41%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options OKTA Okta $242.42 / -16.595 (-6.41%) 03/03/21 Okta drops 13% to $210.50 after Q1, FY22 profit view miss estimates 03/03/21 Okta to acquire Auth0 in deal valued at roughly $6.5B 12/02/20 Okta jumps 6.8% to $246 after Q3 results, FY21 guidance, AWS availability 12/02/20 Okta announces availability of Identity Cloud in AWS Marketplace OKTA Okta $242.42 / -16.595 (-6.41%) 06:45 Today Mizuho Okta price target lowered to $255 from $305 at Mizuho 06:37 Today Baird Okta price target lowered to $240 from $275 at Baird 06:06 Today Piper Sandler Okta price target lowered to $235 from $250 at Piper Sandler 05:44 Today Canaccord Okta upgraded to Buy from Hold at Canaccord OKTA Okta $242.42 / -16.595 (-6.41%) 03/03/21 Okta sees FY22 adjusted EPS (49c)-(44c), consensus 1c 03/03/21 Okta sees Q1 adjusted EPS (21c)-(20c), consensus (7c) 03/03/21 Okta reports Q4 adjusted EPS 6c, consensus (1c) 03/03/21 Notable companies reporting after market close OKTA Okta $242.42 / -16.595 (-6.41%) 03/03/21 Fly Intel: After-Hours Movers 12/21/20 Analysts move to sidelines on SolarWinds following cyberattack 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup 12/02/20 Fly Intel: After-Hours Movers OKTA Okta $242.42 / -16.595 (-6.41%) 12/02/20 Okta options imply 9.8% move in share price post-earnings
Recommendations	Agco price target raised to $145 from $141 at Deutsche Bank » 06:52 03/04/21 03/04 06:52 03/04/21 06:52 AGCO Agco $126.04 / -3.1 (-2.40%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AGCO Agco $126.04 / -3.1 (-2.40%) 03/03/21 AGCO announces farmer-first strategy 02/19/21 Agco says TAFE letter to board makes 'a number of misleading statements' 10/13/20 Agco chief communication officer Ulrich Stockheim to depart company AGCO Agco $126.04 / -3.1 (-2.40%) 02/08/21 BMO Capital Agco price target raised to $155 from $130 at BMO Capital 01/20/21 Vertical Research Agco initiated with a Hold at Vertical Research 01/15/21 Jefferies Agco price target raised to $135 from $105 at Jefferies 01/15/21 Barclays Agco price target raised to $105 from $93 at Barclays AGCO Agco $126.04 / -3.1 (-2.40%) 02/04/21 Agco sees FY21 EPS $7.00-$7.25, consensus $6.28 02/04/21 Agco reports Q4 EPS $1.54, consensus $1.11 11/03/20 Agco raises FY20 adj. EPS view to approximately $5.00 from $3.50-$3.75 11/03/20 Agco reports Q3 EPS $2.09, consensus 98c
Recommendations	Shake Shack price target raised to $107 from $70 at Deutsche Bank » 06:51 03/04/21 03/04 06:51 03/04/21 06:51 SHAK Shake Shack $113.83 / -7.81 (-6.42%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options SHAK Shake Shack $113.83 / -7.81 (-6.42%) 12/11/20 Shake Shack falls with New York City closing indoor dining Monday 10/29/20 Shake Shack not providing full guidance for FY20 10/29/20 Shake Shack: Same-Shack sales improved sequentially every month since April 09/09/20 Cuomo says NYC restaurants can open indoors at 25% capacity Sept. 30 SHAK Shake Shack $113.83 / -7.81 (-6.42%) 02/26/21 Loop Capital Shake Shack price target raised to $150 from $120 at Loop Capital 02/26/21 Barclays Shake Shack price target raised to $100 from $86 at Barclays 02/26/21 Piper Sandler Shake Shack price target raised to $135 from $122 at Piper Sandler 01/25/21 JPMorgan Shake Shack price target raised to $70 from $62 at JPMorgan SHAK Shake Shack $113.83 / -7.81 (-6.42%) 02/25/21 Shake Shack reports Q4 EPS (3c), consensus (11c) 02/25/21 Notable companies reporting after market close 01/12/21 Shake Shack sees FY20 revenue $522.9M, consensus $519.25M 01/12/21 Shake Shack reports preliminary Q4 revenue $157.5M, consensus $153.75M SHAK Shake Shack $113.83 / -7.81 (-6.42%) 10/29/20 Fly Intel: After-Hours Movers 10/23/20 Intel, Fastly downgrades among today's top calls on Wall Street 10/02/20 DexCom downgrade, Shake Shack initiation among today's top calls on Wall Street 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference SHAK Shake Shack $113.83 / -7.81 (-6.42%) 11/30/20 Shake Shack put volume heavy and directionally bearish 11/27/20 Unusual put flow in option market yesterday 11/25/20 Shake Shack put spread seller shows an appetite for risk 09/10/20 Shake Shack call volume above normal and directionally bullish
Hot Stocks	The Buckle reports February comparable store net sales up 5.3% y-o-y » 06:51 03/04/21 03/04 06:51 03/04/21 06:51 BKE The Buckle $37.79 / +0.25 (+0.67%) The Buckle announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly BKE The Buckle $37.79 / +0.25 (+0.67%) 02/04/21 The Buckle reports January net sales $63.1M, up 33.6%, SSS up 35.3% 01/07/21 The Buckle reports December net sales up 17.7% to $169.4M, SSS up 17.9% 12/08/20 The Buckle announces $2.00 per share special cash dividend 12/03/20 The Buckle reports November net sales up 8.1% year-over-year BKE The Buckle $37.79 / +0.25 (+0.67%) 11/20/20 The Buckle reports Q3 EPS 85c, consensus 54c BKE The Buckle $37.79 / +0.25 (+0.67%) 11/20/20 Fly Intel: Pre-market Movers
Hot Stocks	Tapestry's Kate Spade announces new structure for creative organization » 06:51 03/04/21 03/04 06:51 03/04/21 06:51 TPR Tapestry $41.56 / -0.75 (-1.77%) American fashion design… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TPR Tapestry $41.56 / -0.75 (-1.77%) 02/04/21 Tapestry sees increase in demand for key categories as vaccine rollout continues 02/04/21 Tapestry sees Covid-related headwinds persisting in near-term 02/04/21 Tapestry 'optimistic' about potential for Kate Spade brand 12/17/20 Google Cloud announces multi-year agreement with Tapestry TPR Tapestry $41.56 / -0.75 (-1.77%) 02/22/21 Credit Suisse Tapestry upgraded to Outperform with $50 target at Credit Suisse 02/22/21 Credit Suisse Tapestry upgraded to Outperform from Neutral at Credit Suisse 02/16/21 Piper Sandler Tapestry price target raised to $45 from $42 at Piper Sandler 02/09/21 Telsey Advisory Tapestry upgraded to Outperform from Market Perform at Telsey Advisory TPR Tapestry $41.56 / -0.75 (-1.77%) 02/04/21 Tapestry sees FY21 revenue growth in high-single digits, consensus $5.3B 02/04/21 Tapestry reports Q2 non-GAAP EPS $1.15, consensus $1.01 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open TPR Tapestry $41.56 / -0.75 (-1.77%) 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 02/04/21 Fly Intel: Pre-market Movers 11/16/20 Verizon resumption, Tapestry upgrade among today's top calls on Wall Street 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results TPR Tapestry $41.56 / -0.75 (-1.77%) 02/25/21 Tapestry put volume heavy and directionally bearish 11/30/20 Tapestry put volume heavy and directionally bearish 10/19/20 Tapestry call volume above normal and directionally bullish 09/16/20 Unusually active option classes on open September 16th

Recommendations	Braemar Hotels & Resorts price target raised to $12 from $10 at Deutsche Bank » 06:50 03/04/21 03/04 06:50 03/04/21 06:50 BHR Braemar Hotels & Resorts $6.89 / +0.38 (+5.84%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options BHR Braemar Hotels & Resorts $6.89 / +0.38 (+5.84%) 12/10/20 Braemar Hotels & Resorts reports October and November operations BHR Braemar Hotels & Resorts $6.89 / +0.38 (+5.84%) 12/02/20 B. Riley Securities Braemar Hotels & Resorts price target raised to $5 from $4 at B. Riley 06/05/20 B. Riley FBR Braemar Hotels downgraded to Neutral on valuaton at B. Riley FBR 06/05/20 B. Riley FBR Braemar Hotels & Resorts downgraded to Neutral from Buy at B. Riley FBR 03/10/20 DA Davidson Braemar Hotels & Resorts downgraded to Neutral from Buy at DA Davidson BHR Braemar Hotels & Resorts $6.89 / +0.38 (+5.84%) 09/21/20 Largest borrow rate increases among liquid names
Earnings	Summit Midstream reports Q4 EPS $29.73, two estimates $1.07 » 06:50 03/04/21 03/04 06:50 03/04/21 06:50 SMLP Summit Midstream $23.00 / +0.01 (+0.04%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Events SMLP Summit Midstream $23.00 / +0.01 (+0.04%) 02/16/21 Summit Midstream sees Q4 net income $119M-$121M, adj. EBITDA $61M-$63M 02/16/21 Summit Midstream sees FY21 adjusted EBITDA $210M-$230M, CapEx $20M-$35M 01/13/21 Summit Midstream rises 24.6% 01/13/21 Summit Midstream rises 32.4% SMLP Summit Midstream $23.00 / +0.01 (+0.04%) 11/06/20 Summit Midstream reports Q3 revenue $90.15M, two estimates $98.8M 10:00 Today Summit Midstream - SMLP
Hot Stocks	Merck begins tender offer to acquire Pandion Therapeutics for $60 per share » 06:49 03/04/21 03/04 06:49 03/04/21 06:49 MRK Merck $73.30 / +0.46 (+0.63%) , PAND Pandion Therapeutics $61.62 / +0.56 (+0.92%) Merck (MRK) is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRK PAND MRK Merck $73.30 / +0.46 (+0.63%) 03/02/21 Merck to help produce Johnson & Johnson COVID-19 vaccine 03/01/21 Merck announces voluntary withdrawal for KEYTRUDA in SCLC 03/01/21 Merck: FDA accepts gefapixant New Drug Application for review 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash PAND Pandion Therapeutics $61.62 / +0.56 (+0.92%) 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash 02/25/21 Merck, Pandion Therapeutics deal has approx. total equity value of $1.85B 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash 02/22/21 Pandion Therapeutics presents preclinical data on PT001 MRK PAND MRK Merck $73.30 / +0.46 (+0.63%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush PAND Pandion Therapeutics $61.62 / +0.56 (+0.92%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 01/04/21 Goldman Sachs Pandion's PT101 'well-positioned' vs. competitors, says Goldman Sachs 08/11/20 Fly Intel: Top five analyst initiations MRK PAND MRK Merck $73.30 / +0.46 (+0.63%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open PAND Pandion Therapeutics $61.62 / +0.56 (+0.92%) 11/16/20 Pandion Therapeutics reports Q3 EPS (51c), consensus (44c) 17 Jul MRK MRK Merck $73.30 / +0.46 (+0.63%) 03/02/21 Merck to help produce J&J Covid vaccine, Washington Post reports 02/10/21 Merck in talks to produce authorized COVID-19 vaccines, WSJ says 02/03/21 Records show Merck's Propecia has trail of suicide reports, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says MRK PAND MRK Merck $73.30 / +0.46 (+0.63%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday PAND Pandion Therapeutics $61.62 / +0.56 (+0.92%) 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Pre-market Movers 04/09/21 Pharma/Biopharma 03/16/21 Healthcare Corporate Access Virtual Day 04/29/21 Merck - MRK 03/29/21 PDUFA Date for KEYTRUDA 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) 12/21/21 PDUFA Date for Gefapixant MRK MRK Merck $73.30 / +0.46 (+0.63%) 03/02/21 Unusually active option classes on open March 2nd 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish
Recommendations	American Eagle price target raised to $32 from $29 at Citi » 06:49 03/04/21 03/04 06:49 03/04/21 06:49 AEO American Eagle $25.51 / +0.435 (+1.73%) Citi analyst Paul Lejuez… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AEO American Eagle $25.51 / +0.435 (+1.73%) 03/03/21 American Eagle CFO says Q1 revenue, op. income to exceed Q1 of 2019 and 2020 03/03/21 American Eagle reinstates quarterly dividend at 13.75 per share 03/03/21 American Eagle sees FY21 CapEx $250M-$275M 01/21/21 American Eagle targeting 600-700 AE stores in U.S. and Canada AEO American Eagle $25.51 / +0.435 (+1.73%) 02/24/21 Cowen American Eagle upgraded to Outperform from Market Perform at Cowen 02/24/21 Cowen American Eagle upgraded to Outperform from Market Perform at Cowen 01/25/21 RBC Capital American Eagle upgraded to Outperform from Sector Perform at RBC Capital 01/25/21 RBC Capital American Eagle upgraded to Outperform from Sector Perform at RBC Capital AEO American Eagle $25.51 / +0.435 (+1.73%) 03/03/21 American Eagle Outfitters reports Q4 adjusted EPS 39c, consensus 36c 03/03/21 Notable companies reporting after market close 01/21/21 American Eagle sees Q4 revenue down low single digits, consensus $1.31B 11/24/20 American Eagle reports Q3 EPS 35c, consensus 34c AEO American Eagle $25.51 / +0.435 (+1.73%) 11/05/20 American Eagle partners with Disney for holiday collaboration, WWD reports AEO American Eagle $25.51 / +0.435 (+1.73%) 03/03/21 Fly Intel: After-Hours Movers 02/24/21 Square, Workhorse downgrades among today's top calls on Wall Street 11/24/20 Fly Intel: After-Hours Movers 10/14/20 Microsoft resumption, Nio upgrade among top calls on Wall Street AEO American Eagle $25.51 / +0.435 (+1.73%) 12/29/20 American Eagle call volume above normal and directionally bullish 11/24/20 American Eagle options imply 10.4% move in share price post-earnings 10/29/20 American Eagle put volume heavy and directionally bearish 10/19/20 American Eagle put volume heavy and directionally bearish
Hot Stocks	BJ's Wholesale CEO says 2020 'structurally changed our business for the better' » 06:49 03/04/21 03/04 06:49 03/04/21 06:49 BJ BJ's Wholesale $38.69 / -0.1499 (-0.39%) "2020 was a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BJ BJ's Wholesale $38.69 / -0.1499 (-0.39%) 06:47 Today BJ's Wholesale reports Q4 comparable club sales up 15.9%, ex-gasoline 06:46 Today BJ's Wholesale 'to refrain from offering formal detailed guidance' 01/27/21 BJ's Wholesale signs three-year, exclusive partnership with CommerceHub 01/27/21 Citizens announces consumer financing partnership with BJ's Wholesale Club BJ BJ's Wholesale $38.69 / -0.1499 (-0.39%) 01/28/21 Gordon Haskett BJ's Wholesale downgraded to Neutral from Buy at Gordon Haskett 12/14/20 JPMorgan BJ's downgraded to Neutral after recent rally at JPMorgan 12/14/20 JPMorgan BJ's Wholesale downgraded to Neutral from Overweight at JPMorgan 11/23/20 MKM Partners BJ's Wholesale price target raised to $41 from $37 at MKM Partners BJ BJ's Wholesale $38.69 / -0.1499 (-0.39%) 06:45 Today BJ's Wholesale reports Q4 adjusted EPS 70c, consensus 67c 03/03/21 Notable companies reporting before tomorrow's open 03/03/21 Notable companies reporting before tomorrow's open 11/19/20 BJ's Wholesale reports Q3 adjusted EPS 92c, consensus 64c BJ BJ's Wholesale $38.69 / -0.1499 (-0.39%) 12/10/20 Goldman Sachs says buy Floor & Decor, sell Best Buy 11/19/20 Fly Intel: Pre-market Movers 10/29/20 Pinterest, Bed Bath & Beyond upgrades among today's top calls on Wall Street 08:30 Today BJ's Wholesale - BJ

Events

Earnings calls, analyst events, roadshows and more

Today at 07:30

Challenger Job-Cut Report Level: February 2021 Government Event
HCM
Today at 08:00

Hutchison China MediTech - HCM Conference Calls
BALY
Today at 08:00

Bally's - BALY Conference Calls
ATC
Today at 08:00

Atotech - ATC Conference Calls
WVE
Today at 08:00

Wave Life Sciences - WVE Conference Calls
FULC
Today at 08:00

Fulcrum Therapeutics - FULC Conference Calls
Today at 08:00

Consumer Data Analytics Industry Meetings
Today at 08:30

Initial Jobless Claims Change: Week 2/27/2021 Government Event
Today at 08:30

Jobless Claims: 4-Week Moving Average: Week 2/27/2021 Government Event
Today at 08:30

Productivity & Costs: Non-farm Poductivity Annual Rate: Q4(r):2020 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50-47.00 3.9M Shares GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James $34.00-35.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR $11.50-11.75 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

Marlowe initiated with a Buy at Peel Hunt

TODAY'S FREE FLY STORIES

Get Full Fly Access